SRF Résultats passés
Passé contrôle des critères 4/6
Les bénéfices de SRF ont diminué à un taux annuel moyen de -2.8%, tandis que le secteur Chemicals a vu ses bénéfices augmenter de en à 6.7% par an. Les revenus ont augmenté de en à un taux moyen de 7.5% par an. Le rendement des capitaux propres de SRF est 13.1% et ses marges nettes sont de 11.6%.
Informations clés
-2.82%
Taux de croissance des bénéfices
-2.98%
Taux de croissance du BPA
| Chemicals Croissance de l'industrie | 17.68% |
| Taux de croissance des recettes | 7.54% |
| Rendement des fonds propres | 13.07% |
| Marge nette | 11.63% |
| Dernière mise à jour des bénéfices | 31 Mar 2026 |
Mises à jour récentes des performances passées
Recent updates
503806: Future P/E Compression Will Likely Cap Upside Despite Margin Support
The analyst price target for SRF has been adjusted from ₹2,249.74 to ₹2,200.00 as analysts factor in updated assumptions on discount rate, revenue growth, profit margin and future P/E. What's in the News SRF has scheduled a board meeting on May 05, 2026 to consider and approve the audited financial results for the quarter and year ended March 31, 2026 (company filing).503806: Fair View As Higher Margins Offset Lower Future P/E Multiple
Analysts have raised their fair value estimate for SRF slightly, from ₹2,239.45 to ₹2,249.74. This reflects updated assumptions for revenue growth, profit margins, a lower assumed discount rate, and a reduced future P/E multiple.503806: Elevated P E And Margins Will Likely Restrain Future Returns
Analysts have modestly increased their fair value estimate for SRF from ₹2,218.36 to ₹2,239.45, citing updated assumptions regarding revenue growth, profit margins, the discount rate, and future P/E, which together support a slightly higher price target. What's in the News SRF's board approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.503806: Elevated P E And Modest Margins Will Likely Restrain Future Returns
Analysts now set their fair value estimate for SRF at ₹2,218, compared with the previous ₹2,244. This reflects updated assumptions around discount rate, revenue growth, profit margins and future P/E expectations.503806: Elevated P E And Modest Margin Outlook Will Likely Pressure Returns
Analysts have slightly raised their price target on SRF to ₹2,244, citing updated assumptions for the discount rate, revenue growth, profit margin and future P/E. These changes keep their fair value view broadly unchanged in headline terms but reflect a modestly adjusted risk and earnings profile.503806: Lower Margins And Rich P E Will Likely Pressure Returns
Analysts have raised their price target on SRF to ₹2,244 from ₹2,213, citing updated assumptions on the discount rate, revenue growth, profit margins and a higher future P/E multiple. What's in the News The board has approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.
503806: New Pharma Plant And CFO Appointment Will Support Future Upside
Analysts have trimmed their price target on SRF to ₹3,155.83 from ₹3,183.00, reflecting slightly more conservative assumptions on revenue growth, profit margin and future P/E, as well as a marginally higher discount rate. What's in the News Board meeting on January 20, 2026 to review unaudited financial results for the quarter and nine months ended December 31, 2025, consider a new pharma intermediate plant project, and discuss a second interim dividend for FY 2025-26 (company filing).
503806: Future Capacity Expansion And CFO Transition Will Support Long Term Prospects
Analysts have kept their fair value estimate for SRF steady at ₹3,841, with only small tweaks to assumptions such as the discount rate, revenue growth, profit margin and future P/E that feed into the updated target. This signals broadly consistent expectations compared with prior research.503806: Future Specialty Fluoropolymer Capacity Expansion May Support Long Term Profitability
Analysts have modestly raised their price target on SRF to a new level, in line with incremental improvements in projected revenue growth, profit margins, and a slightly lower future valuation multiple, signaling a cautiously stronger outlook for the stock. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025, with SRF initiating the process to identify a successor and ensure a smooth transition (Key Developments).503806: Lower Discount Rate May Support Stronger Long Term Profitability
Analysts have raised their fair value estimate for SRF by approximately $191 to $3,841 per share, citing a modestly lower discount rate and slightly higher long term profit margin expectations that more than offset a small reduction in projected revenue growth. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025.503806: CFO Transition And New Facility Approval Will Drive Upside Ahead
Analysts have adjusted their price target for SRF slightly upward from $3,182.93 to $3,183.00, citing minor changes in underlying financial assumptions such as discount rate and projected margin. What's in the News Chief Financial Officer Rahul Jain will step down at the close of business on December 12, 2025.503806: Upcoming CFO Departure And Facility Decision Will Shape Outlook
Analysts have raised their price target for SRF from $3,138.07 to $3,182.93, citing updated forecasts that reflect slight adjustments in growth and profitability assumptions. What's in the News SRF Limited's Chief Financial Officer, Rahul Jain, announced he will step down from his position at the close of business on December 12, 2025.New Facility And Supply Chain Moves Will Drive Balanced Opportunity Ahead
Analysts have slightly raised their price target for SRF from $3,137.83 to $3,138.07, citing improved profit margin projections as well as a modest increase in anticipated revenue growth. What's in the News SRF Limited will hold a Board Meeting on October 27, 2025, to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2025.Sustainability And Capacity Upgrades Will Transform Specialty Chemicals
Analysts have increased their price target for SRF from $3,104.79 to $3,137.83, reflecting updated expectations for the company's financial outlook. What's in the News The Chemours Company and SRF Limited have signed strategic agreements to enhance the global supply chain for fluoropolymers and fluoroelastomers (Key Developments).Sustainability And Capacity Upgrades Will Transform Specialty Chemicals
With no meaningful change in either the discount rate or forward P/E multiple, analysts have maintained SRF's fair value estimate at ₹3105. What's in the News SRF Limited has entered into strategic agreements with The Chemours Company to strengthen Chemours' global supply chain for fluoropolymers and fluoroelastomers, leveraging SRF's manufacturing capabilities.
Specialty Chemicals Innovations And Global Demand Empower Revenue Growth Journey
SRF's Specialty Chemicals growth and increased production should drive revenue and improve margins due to new product launches and efficiency gains.Ventilation des recettes et des dépenses
Comment SRF gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Mar 26 | 157,865 | 18,352 | 11,483 | 0 |
| 31 Dec 25 | 154,847 | 17,792 | 11,548 | 0 |
| 30 Sep 25 | 152,635 | 16,176 | 11,347 | 0 |
| 30 Jun 25 | 150,476 | 14,309 | 11,110 | 0 |
| 31 Mar 25 | 146,931 | 12,508 | 10,859 | 0 |
| 31 Dec 24 | 139,495 | 11,469 | 10,547 | 0 |
| 30 Sep 24 | 135,112 | 11,293 | 10,378 | 0 |
| 30 Jun 24 | 132,643 | 12,286 | 10,110 | 0 |
| 31 Mar 24 | 131,385 | 13,357 | 9,768 | 0 |
| 31 Dec 23 | 133,469 | 14,760 | 9,422 | 0 |
| 30 Sep 23 | 137,635 | 17,334 | 9,086 | 0 |
| 30 Jun 23 | 143,139 | 19,136 | 8,772 | 0 |
| 31 Mar 23 | 148,703 | 21,623 | 8,535 | 0 |
| 31 Dec 22 | 146,416 | 22,055 | 8,435 | 0 |
| 30 Sep 22 | 145,178 | 22,002 | 8,401 | 0 |
| 30 Jun 22 | 136,290 | 21,016 | 8,226 | 0 |
| 31 Mar 22 | 124,337 | 18,889 | 8,104 | 0 |
| 31 Dec 21 | 114,919 | 16,647 | 7,597 | 0 |
| 30 Sep 21 | 102,924 | 14,834 | 7,108 | 0 |
| 30 Jun 21 | 95,543 | 14,167 | 6,659 | 0 |
| 31 Mar 21 | 84,000 | 11,983 | 6,393 | 0 |
| 31 Dec 20 | 76,502 | 10,110 | 6,079 | 0 |
| 30 Sep 20 | 73,543 | 10,322 | 5,868 | 0 |
| 30 Jun 20 | 69,913 | 9,174 | 5,652 | 0 |
| 31 Mar 20 | 72,094 | 9,159 | 5,567 | 0 |
| 31 Dec 19 | 78,817 | 9,511 | 6,060 | 0 |
| 30 Sep 19 | 78,411 | 7,592 | 5,862 | 0 |
| 30 Jun 19 | 71,216 | 6,331 | 4,993 | 0 |
| 31 Mar 19 | 70,996 | 5,916 | 4,901 | 0 |
| 31 Dec 18 | 72,329 | 5,747 | 5,306 | 0 |
| 30 Sep 18 | 66,660 | 5,402 | 5,199 | 0 |
| 30 Jun 18 | 60,370 | 4,917 | 4,777 | 0 |
| 31 Mar 18 | 55,890 | 4,617 | 5,035 | 0 |
| 31 Dec 17 | 53,026 | 4,670 | 4,951 | 0 |
| 30 Sep 17 | 50,385 | 4,442 | 4,827 | 0 |
| 30 Jun 17 | 48,952 | 4,642 | 4,465 | 0 |
| 31 Mar 17 | 48,218 | 5,150 | 4,585 | 0 |
| 31 Dec 16 | 45,833 | 4,787 | 4,491 | 0 |
| 30 Sep 16 | 45,459 | 4,709 | 4,363 | 0 |
| 30 Jun 16 | 45,980 | 4,537 | 4,016 | 0 |
| 31 Mar 16 | 45,927 | 4,299 | 4,094 | 0 |
| 31 Dec 15 | 45,353 | 3,746 | 5,788 | 0 |
| 30 Sep 15 | 45,511 | 3,453 | 5,722 | 0 |
| 30 Jun 15 | 45,759 | 3,235 | 5,701 | 0 |
Des revenus de qualité: 503806 a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de 503806 sont plus élevées que l'année dernière 503806. (11.6%) sont plus élevées que l'année dernière (8.5%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de 503806 ont diminué de 2.8% par an au cours des 5 dernières années.
Accélération de la croissance: La croissance des bénéfices de 503806 au cours de l'année écoulée ( 46.7% ) dépasse sa moyenne sur 5 ans ( -2.8% par an).
Bénéfices par rapport au secteur d'activité: La croissance des bénéfices 503806 au cours de l'année écoulée ( 46.7% ) a dépassé celle du secteur Chemicals 10.4%.
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de 503806 ( 13.1% ) est considéré comme faible.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/22 11:53 |
| Cours de l'action en fin de journée | 2026/05/22 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2026/03/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
SRF Limited est couverte par 42 analystes. 31 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| null null | 360 ONE Capital Market Private Limited |
| Kumar Saumya Singh | Ambit Capital |
| Nitin Bhasin | Ambit Capital |